Recerca > Càncer

Grup de recerca de biomarcadors en càncer (GReBiC)

Nombre de publicacions
495
Cercador de publicacions
  • Griguolo, G; Serna, G; Pascual, T; Fasani, R; Guardia, X; Chic, N; Pare, L; Pernas, S; Munoz, M; Oliveira, M; Vidal, M; Llombart-Cussac, A; Cortes, J; Galvan, P; Bermejo, B; Martinez, N; Lopez, R; Morales, S; Garau, I; Manso, L; Alarcon, J; Martinez, E; Villagrasa, P; Prat, A; Nuciforo, P

    Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

    npj Precision Oncology 5 -. .

    [doi:10.1038/s41698-021-00163-6]

  • Bielsa S; Bernet A; Civit C; Acosta C; Manonelles A; Porcel JM

    FluoroType® MTB in pleural fluid for diagnosing tuberculosis.

    REVISTA CLINICA ESPANOLA 221 139-144. .

    [doi:10.1016/j.rce.2020.04.010]

  • Morales Murillo, Serafin; Gasol Cudos, Ariadna; Veas Rodriguez, Joel; Canosa Morales, Carles; Melé Olivé, Jordi; Vilardell Villellas, Felip; Sanchez Guzman, Douglas Rene; Iglesias Martínez, Edelmiro; Salud Salvia, Antonieta

    Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

    BREAST 56 35-41. .

    [doi:10.1016/j.breast.2021.01.001]

  • Murillo, SM; Cudos, AG; Rodriguez, JV; Morales, CC; Olive, JM; Villellas, FV; Guzman, DRS; Martinez, EI; Salvia, AS

    Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

    Future Science Oa 7 -. .

    [doi:10.2144/fsoa-2020-0146]

  • Chan A; Moy B; Mansi J; Ejlertsen B; Holmes FA; Chia S; Iwata H; Gnant M; Loibl S; Barrios CH; Somali I; Smichkoska S; Martinez N; Alonso MG; Link JS; Mayer IA; Cold S; Murillo SM; Senecal F; Inoue K; Ruiz-Borrego M; Hui R; Denduluri N; Patt D; Rugo HS; Johnston SRD; Bryce R; Zhang B; Xu F; Wong A; Martin M; ExteNET Study Group

    Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

    CLINICAL BREAST CANCER 21 80-917. .

    [doi:10.1016/j.clbc.2020.09.014]

  • Murillo, SM; Cudos, AG; Subirats, OP; Olive, JM; Morales, CC; Villellas, FV; Guzman, DRS; Rodriguez, JV; Galindo, AR

    Axillary management after neoadjuvant chemotherapy in initially node positive early breast cancer

    CANCER RESEARCH 81 -. .

  • Oliveira, M; Villagrasa, P; Ciruelos, E; Gavila, J; Cortegoso, A; Henao, F; Vega, E; Bofill, JS; Quiroga, V; Garcia-Estevez, L; Morales, S; Tolosa, P; Celiz, P; Farre, XG; Saura, C

    Solti-1507 A phase ib study of ipatasertib and anti-her2 therapy in her2-positive advanced breast cancer with pik3ca mutation (ipather)

    CANCER RESEARCH 81 -. .

  • Prat, A; Gavila, J; Pernas, S; Cruz, J; Saura, C; Nogales, E; Bermejo, M; Bofill, JS; Quiroga, V; Garcia-Estevez, L; Morales, S; Servitja, S; del Toro, R; Galvan, P; Chic, N; Martinez, D; Braso-Maristany, F; Canes, J; Pare, L; Ferrero-Cafiero, JM; Villagrasa, P

    Solti-1804 HER2-PREDICT: A biomarker research study of DS8201-A-U301-U302 and-U303 trials

    CANCER RESEARCH 81 -. .

  • Saura, C; Ciruelos, E; Vidal, M; Garrigos, L; Margeli, M; Morales, S; Gonzalez-Farre, X; Bofill, JS; Blancas, I; Gasent, JM; Lopez-Miranda, E; Godoy, A; Iglesias, M; Sanchez-Rovira, P; Hernao, F; Gallegos, I; Pulido, C; Alves, S; Branco, D; Passos-Coelho, J; Escriva-de-Romani, S; Ferrero-Cafiero, JM; Villagrasa, P; Prat, A

    Solti-1718 NEREA trial: Neratinib in hormone receptor (HR)-positive/HER2-negative HER2-Enriched (HER2-E) advanced breast cancer (BC)

    CANCER RESEARCH 81 -. .

  • Schmid P; Sablin MP; Bergh J; Im SA; Lu YS; Martínez N; Neven P; Lee KS; Morales S; Pérez-Fidalgo JA; Adamson D; Gonçalves A; Prat A; Jerusalem G; Schlieker L; Espadero RM; Bogenrieder T; Huang DC; Crown J; Cortés J

    A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.

    BREAST CANCER RESEARCH 23 8-8. .

    [doi:10.1186/s13058-020-01382-8]

  • Porcel JM

    Review of Medical Therapy in the Emergency Department.

    REVISTA CLINICA ESPANOLA 221 68-68. .

    [doi:10.1016/j.rce.2020.08.001]

  • Cudos, AG; Murillo, SM; Subirats, OP; Villellas, FV; Guzman, DRS; Morales, CC; Olive, JM; Sanchez, AV; Ortega, JFC

    Relapse pattern after neoadjuvant treatment in early breast cancer

    ANNALS OF ONCOLOGY 32 437-437. .

    [doi:10.1016/j.annonc.2021.08.461]